Hyposmia: Clinical Trials

2 trials for Hyposmia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 recruiting. 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 32Completed 1, Recruiting 1

Follow Hyposmia: new trials by email Literature Review of Hyposmia trials Research Report on Hyposmia

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Topical Versus Injection PRP for Olfactory Dysfunction
Intranasal Injection of Autologous PRP, Carrier-Assisted Topical Application of Autologous PRP, platelet-rich plasma - Olfactory Dysfunction, Anosmia
Phase 3RecruitingTaipei Veterans General Hospital, Taiwan602025-09-112026-10-05
Intranasal Insulin for COVID-19-related Smell Loss
Insulin - Anosmia, Smell Loss
Phase 3CompletedUniversidad Panamericana272021-01-042022-07-18

Narrower conditions

Anosmia (2)  ·  COVID-19 (1)  ·  Olfaction Disorders (1)

Broader conditions

Nervous System Diseases (2)  ·  Neurologic Manifestations (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Sensation Disorders (2)  ·  Signs and Symptoms (2)  ·  Coronaviridae Infections (1)  ·  Coronavirus Infections (1)  ·  Infections (1)  ·  Lung Diseases (1)  ·  Nidovirales Infections (1)  ·  Olfaction Disorders (1)  ·  Pneumonia (1)  ·  Pneumonia, Viral (1)  ·  RNA Virus Infections (1)  ·  Respiratory Tract Diseases (1)

Interventions

Insulin (1)  ·  Olfactory Training (1)

Sponsors

Taipei Veterans General Hospital, Taiwan (1)  ·  Universidad Panamericana (1)

Countries

Mexico (1)  ·  Taiwan (1)

Results publications

PMID 29557250, PMID 33862126